FDA device listing

BD COR MX™ Instrument,BD COR PX™ Instrument,BD CTGCTV2

FDA device listing 1233837644 · Becton Dickinson and Company

Key facts

Proprietary names BD COR MX™ Instrument,BD COR PX™ Instrument,BD CTGCTV2
Owner/operator Becton Dickinson and Company
Owner/operator number 9922032
Premarket submissions K210585
Product codes LSL, MKZ, OUY, QEP
Device names LSL - Dna-Reagents, Neisseria, MKZ - Dna Probe, Nucleic Acid Amplification, Chlamydia, OUY - Trichomonas Vaginalis Nucleic Acid Amplification Test System, QEP - Nucleic Acid Detection System For Non-Viral Microorganism(S) Causing Sexually Transmitted Infections
Device class Class I, Class II
Classification regulations (21 CFR) 866.3120, 866.3390, 866.3393, 866.3860
Review panels Immunology, Microbiology
Registered establishments BECTON, DICKINSON & CO., GeneOhm Sciences Canada, ULC.
Establishment registrations 1119779, 3007420875
FEI numbers 1119779, 3007420875
Establishment operations Complaint File Establishment, Manufacturer, Specification Developer
Registration valid through 2026

At a glance

  • 1–9 Registered establishments listing this device
  • 1–9 UDI devices (GUDID) under the same submission
  • 1–9 Device listings citing the same submission
  • Yes Premarket submission listed

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA device listings

Establishments that make or process devices for the U.S. market must list each device with the FDA. A listing records the device's proprietary names, product codes and premarket submission, and every registered establishment that handles it.

Source: U.S. Food and Drug Administration (FDA), Establishment Registration and Device Listing database

Browse all FDA device listings